DOP2014000142A - VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN - Google Patents

VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Info

Publication number
DOP2014000142A
DOP2014000142A DO2014000142A DO2014000142A DOP2014000142A DO P2014000142 A DOP2014000142 A DO P2014000142A DO 2014000142 A DO2014000142 A DO 2014000142A DO 2014000142 A DO2014000142 A DO 2014000142A DO P2014000142 A DOP2014000142 A DO P2014000142A
Authority
DO
Dominican Republic
Prior art keywords
release
women
useful
vaginal ring
continuous use
Prior art date
Application number
DO2014000142A
Other languages
Spanish (es)
Inventor
Shu-Chen Chen
Marianela Del Carmen Beltrán Apablaza
Original Assignee
Andrómaco S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrómaco S A Lab filed Critical Andrómaco S A Lab
Priority to DO2014000142A priority Critical patent/DOP2014000142A/en
Publication of DOP2014000142A publication Critical patent/DOP2014000142A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anillo vaginal de liberación sostenida que comprende meloxicam y un agente modulador de la liberación del principio activo, tal como polivinilpirrolidona K-30, que libera el principio activo por al menos 90 días, útil como anticonceptivo de uso continuo en mujeres. El anillo vaginal comprende preferentemente 5% a 30% en peso de meloxicam, en relación al peso total de la formulación.Sustained-release vaginal ring comprising meloxicam and an active substance release modulating agent, such as polyvinylpyrrolidone K-30, which releases the active substance for at least 90 days, useful as a contraceptive for continuous use in women. The vaginal ring preferably comprises 5% to 30% by weight of meloxicam, in relation to the total weight of the formulation.

DO2014000142A 2014-06-18 2014-06-18 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN DOP2014000142A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2014000142A DOP2014000142A (en) 2014-06-18 2014-06-18 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2014000142A DOP2014000142A (en) 2014-06-18 2014-06-18 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Publications (1)

Publication Number Publication Date
DOP2014000142A true DOP2014000142A (en) 2014-08-15

Family

ID=51519415

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2014000142A DOP2014000142A (en) 2014-06-18 2014-06-18 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Country Status (1)

Country Link
DO (1) DOP2014000142A (en)

Similar Documents

Publication Publication Date Title
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
DOP2017000261A (en) CYCLHEXAN DERIVATIVES REPLACED WITH AMIDO
CO2017001493A2 (en) Kits comprising tigit inhibitors and anticancer agents
CL2019000571A1 (en) Carbamate formulations of (r) -2-amino-3-phenylpropyl.
CL2015001984A1 (en) (divisional sol. 1567-2013) combinations of active ingredients comprising pyridylethylbenzamides and other active ingredients.
CR20140365A (en) CARBAMATE COMPOUNDS AND PREPARATION AND USE OF THE SAME
CR20160433A (en) NEW COMPOUNDS
CL2017003437A1 (en) Solid oral formulation containing irinotecan and method of preparation thereof
UY37705A (en) NEW BICYCLIC PIRAZOL DERIVATIVES
AR095691A1 (en) FORMULATION OF AMORFO L-5-METHYLETHYDROPHOLATE (L-5-MTHF-Ca), PROCEDURE, USE
CO2017001842A2 (en) Article and method to maintain menstrual flow inside the vagina
DOP2016000268A (en) AMIDO-AZOLE COMPOUNDS SUBSTITUTED AS TNKS1 AND/OR TNKS2 INHIBITORS
UY35848A (en) TIENOPIRIMIDINS
MX2020004063A (en) Systems and methods to produce b cells genetically modified to express selected antibodies.
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
NI201400066A (en) VAGINAL RING THAT INCLUDES MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
CO2020002624A2 (en) Formulation for topical use for the control and prevention of parasites in animals
MX2017007856A (en) Oral care composition.
DOP2014000142A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
CO7131364A2 (en) Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women
ECSP14008154A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS A CONTINUOUS USE CONTRACEPTIVE IN WOMEN
CR20140302A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
AR088705A1 (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS A CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
PE20142079A1 (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
CL2017000088A1 (en) New fixed combination of adapalene and benzoyl peroxide for the treatment of severe acne.